Track Senseonics Holdings, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Senseonics Holdings, Inc. SENS · Stock Open Senseonics Holdings, Inc. in new tab

10.58 USD
EPS
-2.23
P/B
6.92
ROE
-157.32
Beta
1.03
Target Price
13.83 USD
Senseonics Holdings, Inc. logo

Senseonics Holdings, Inc.

🧾 Earnings Recap – Q3 2026

Senseonics reported record Q3 revenue and raised full-year guidance, while the stock rose 2.3%—a roughly flat reaction. The quarter showed accelerating commercial adoption, though the transcript also places significant future growth hopes on upcoming pump integrations and the Freedom development program.

  • Q3 revenue was $19.6 million, up about 140% year over year; U.S. revenue rose about 160% to $16.8 million, and international revenue grew about 65% to $2.8 million.
  • Full-year revenue guidance increased to $68 million–$70 million from $62 million–$66 million. Management said sales were running ahead of its earlier expectations.
  • The company reported record shipment volume and new patient starts. Active prescribers were up over 90% year over year, and approximately 9 out of 10 new insertions came from patients switching from competing sensors.
  • The Beta Bionics iLet integration is expected to launch in the coming weeks, with first patients possible before year-end; management sees it as an additional growth source in 2027.
  • Freedom entered first-in-human testing on October 26. The pivotal study is expected to start in 2027, with a potential launch targeted for 2028.
📅
Loading chart...
Key Metrics
Earnings dateMarch 1, 2027
EPS-2.23
Book Value1.42
Price to Book6.92
Debt/Equity78.71
% Insiders9.870%
Growth
Revenue Growth1.42%
Estimates
Forward P/E-5.08
Forward EPS-1.93
Target Mean Price13.83

DCF valuation

Model fair value for Senseonics Holdings, Inc. (SENS)
Result
Sign in to run the valuation for SENS.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
6 analysts · consensus Buy · mean target 13.83 USD (low 9.00, high 18.00) · as of 10 Nov 2026
Low 9.00
Mean 13.83
High 18.00
Price 10.58
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Senseonics Holdings, Inc. Logo Senseonics Holdings, Inc. Analysis (SENS)

United States Health Care Official Website Stock

Is Senseonics Holdings, Inc. a good investment? Senseonics Holdings, Inc. (SENS) is currently trading at 10.58 USD. Market analysts have a consensus price target of 13.83 USD. This suggests a potential upside from current levels.

Earnings Schedule: Senseonics Holdings, Inc. is expected to release its next earnings report on March 1, 2027. The market consensus estimate for Forward EPS is -1.93.

Investor FAQ

Does Senseonics Holdings, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Senseonics Holdings, Inc.?

Senseonics Holdings, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 1, 2027. The company currently has a trailing EPS of -2.23.

Company Profile

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Exchange Ticker
ASE (United States) SENS
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Oct. 20, 2025 1:20
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion